Methanesulfonyl chloride → HCID 67117743, compound

HRID 1881011Notes

Reaction equation

HRID 1881011 reaction equation
[NH:1]1[CH2:4][CH:3]([NH:5][C:6](=[O:37])[C:7]2[CH:12]=[C:11]([O:13][CH3:14])[C:10]([NH:15][C:16]3[N:17]=[CH:18][C:19]4[N:25]([CH3:26])[C:24](=[O:27])[C:23]([F:29])([F:28])[CH2:22][N:21]([CH:30]5[CH2:34][CH2:33][CH2:32][CH2:31]5)[C:20]=4[N:35]=3)=[CH:9][C:8]=2F)[CH2:2]1.CCN(C(C)C)C(C)C.[CH3:47][S:48](Cl)(=[O:50])=[O:49]>C(Cl)Cl>[CH:30]1([N:21]2[CH2:22][C:23]([F:28])([F:29])[C:24](=[O:27])[N:25]([CH3:26])[C:19]3[CH:18]=[N:17][C:16]([NH:15][C:10]4[CH:9]=[CH:8][C:7]([C:6]([NH:5][CH:3]5[CH2:4][N:1]([S:48]([CH3:47])(=[O:50])=[O:49])[CH2:2]5)=[O:37])=[CH:12][C:11]=4[O:13][CH3:14])=[N:35][C:20]2=3)[CH2:34][CH2:33][CH2:32][CH2:31]1

Participants

5

Procedure

To a solution of N-(azetidin-3-yl)-4-(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-2-fluoro-5-methoxybenzamide (100 mg, 0.19 mmol) in DCM (2.5 mL, 1:2:2) was added DIEA (50 μL, 0.285 mmol), followed by methanesulfonyl chloride (23 μL, 0.21 mmol). After stirring overnight the solvent was removed and the product purified by reverse phase HPLC, free based, and lyophilized to yield a white solid (9.3 mg, 9%). 1H NMR (400 MHz, DMSO-d6) δ ppm 1.54-1.79 (m, 6 H) 1.96 (br. s., 2 H) 3.05 (s, 3 H) 3.92 (s, 3 H) 3.94 (d, J=1.77 Hz, 2 H) 4.03-4.15 (m, 4 H) 4.61-4.72 (m, 1 H) 4.76-4.87 (m, 1 H) 7.24 (d, J=6.57 Hz, 1 H) 8.08 (s, 1 H) 8.27 (d, 1 H) 8.31 (s, 1 H) 8.73 (d, J=3.79 Hz, 1 H). [M+H] calc'd for C25H30F3N7O5S, 598; found 598.

Workup

  1. customwas removed
  2. customthe product purified by reverse phase HPLC

Sources & evidence

ORD record
ord-ac6e568feb3340b88d7c92c3dfdecc54
Source dataset
uspto-grants-2012_11
Patent number
US08318727B2

Reaction notes

Loading…